JCVI advises use of additional bivalent vaccine for autumn booster campaign

JCVI advises use of additional bivalent vaccine for autumn booster campaign Following on from the previous advice on which vaccines should be used in this year’s autumn booster programme, the Joint Committee on Vaccination and Immunisation (JCVI) has updated its published advice to include an additional bivalent vaccine now approved by the Medicines and Healthcare products Regulatory Agency (MHRA). UK Health Security Agency

See also:

• Independent report: COVID-19 vaccines for autumn 2022: JCVI advice, 3 September 2022 Department of Health and Social Care
• Guidance: The R value and growth rate UK Health Security Agency
• Research: Consensus statements and medium-term projections on COVID-19 UK Health Security Agency
• Guidance: Emerging infections and zoonoses: epidemic intelligence scanning procedures UK Health Security Agency